The Risk Of Dangerous Blood Clots And Strokes

The Risk Of Dangerous Blood Clots And Strokes.
A unusual anti-clotting treat to reduce the risk of dangerous blood clots and strokes in males and females with a type of heart rhythm disorder has been approved by the US Food and Drug Administration. Savaysa (edoxaban) is approved to pay for people with atrial fibrillation that's not caused by a heart valve problem. Atrial fibrillation - the most average type of heart rhythm disorder - increases the jeopardy of developing blood clots that can travel to the brain and cause a stroke.

Savaysa pills are also approved to expound deep vein thrombosis and pulmonary embolism in people already treated with an injected or infused anti-clotting cure for five to 10 days, according to the FDA. Deep vein thrombosis is a blood clot that forms in a involved vein, usually in the lower leg or thigh. Pulmonary embolism is a potentially wearisome condition that occurs when a deep vein blood clot breaks off and travels to an artery in the lungs, blocking blood flow.